Literature DB >> 7819032

Pathological and biological features of mammographically detected invasive breast carcinomas.

R Rajakariar1, R A Walker.   

Abstract

The pathological and biological features of a consecutive series of impalpable invasive breast carcinoma, detected by mammography in the prevalent round of the breast screening programme, have been compared with a clinically presenting group of carcinomas in age-matched patients. There was a significantly higher prevalence of tubular carcinomas as well-differentiated infiltrating ductal carcinomas in the mammographically detected group, and a lower prevalence of poorly differentiated infiltrating ductal carcinomas. Lymph node metastasis was found in 6.5% of the impalpable group compared with 53% of the clinical group. The prevalence of oestrogen receptor was much higher in the impalpable group (96%) than in the control group (67%), although there were no significant differences for progesterone receptor. The prevalence of pS2 was also much higher in the impalpable group, as was cathepsin D. This finding is surprising in view of the reported relationship between cathepsin D and poorer survival. p53 and c-erb-2 proteins were detectable in fewer impalpable carcinomas. The mean MIBI (Ki-67) index was lower in the impalpable group (11.6) than in the clinical group (15.25). Within the mammographically detected group there was a significant difference in the MIBI index between tubular carcinomas and the different grades of infiltrating ductal carcinomas, with a wide range in each category but no association with size. The impalpable carcinomas detected by mammography differ from clinically presenting carcinomas in many ways, raising the question of whether a proportion or all would progress (dedifferentiate) with time.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7819032      PMCID: PMC2033448          DOI: 10.1038/bjc.1995.31

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. British Quality Control Group.

Authors:  R A McClelland; D Wilson; R Leake; P Finlay; R I Nicholson
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

2.  Edinburgh trial of screening for breast cancer: mortality at seven years.

Authors:  M M Roberts; F E Alexander; T J Anderson; U Chetty; P T Donnan; P Forrest; W Hepburn; A Huggins; A E Kirkpatrick; J Lamb
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

3.  Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

Authors:  F Spyratos; T Maudelonde; J P Brouillet; M Brunet; A Defrenne; C Andrieu; K Hacene; A Desplaces; J Rouëssé; H Rochefort
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

4.  Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project.

Authors:  T J Anderson; J Lamb; F Alexander; W Lutz; U Chetty; A P Forrest; A Kirkpatrick; B Muir; M M Roberts; A Huggins
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

5.  Prediction of relapse and survival in breast cancer patients by pS2 protein status.

Authors:  J A Foekens; M C Rio; P Seguin; W L van Putten; J Fauque; M Nap; J G Klijn; P Chambon
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

6.  Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study.

Authors:  J A Henry; A L McCarthy; B Angus; B R Westley; F E May; S Nicholson; J Cairns; A L Harris; C H Horne
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

7.  Cathepsin D and prognosis in breast cancer.

Authors:  A K Tandon; G M Clark; G C Chamness; J M Chirgwin; W L McGuire
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

8.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

9.  Comparative pathology of breast cancer in a randomised trial of screening.

Authors:  T J Anderson; J Lamb; P Donnan; F E Alexander; A Huggins; B B Muir; A E Kirkpatrick; U Chetty; W Hepburn; A Smith
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

10.  pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.

Authors:  J A Henry; N H Piggott; U K Mallick; S Nicholson; J R Farndon; B R Westley; F E May
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more
  8 in total

Review 1.  The molecular pathology of breast cancer progression.

Authors:  Alessandro Bombonati; Dennis C Sgroi
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

2.  Association of pS2 (TFF1) release with breast tumour proliferative rate: in vitro and in vivo studies.

Authors:  S J Reshkin; T Tedone; M Correale; A Mangia; V Casavola; A Paradiso
Journal:  Cell Prolif       Date:  1999 Apr-Jun       Impact factor: 6.831

3.  Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.

Authors:  S A Chappell; T Walsh; R A Walker; J A Shaw
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Genomic heterogeneity of breast tumor pathogenesis.

Authors:  Rachel E Ellsworth; Jeffrey A Hooke; Craig D Shriver; Darrell L Ellsworth
Journal:  Clin Med Oncol       Date:  2009-07-29

5.  Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer.

Authors:  K A Scott; R A Walker
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Breast carcinomas occurring in young women (< 35 years) are different.

Authors:  R A Walker; E Lees; M B Webb; S J Dearing
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

7.  Common variants in breast cancer risk loci predispose to distinct tumor subtypes.

Authors:  Thomas U Ahearn; Haoyu Zhang; Montserrat García-Closas; Nilanjan Chatterjee; Kyriaki Michailidou; Roger L Milne; Manjeet K Bolla; Joe Dennis; Alison M Dunning; Michael Lush; Qin Wang; Irene L Andrulis; Hoda Anton-Culver; Volker Arndt; Kristan J Aronson; Paul L Auer; Annelie Augustinsson; Adinda Baten; Heiko Becher; Sabine Behrens; Javier Benitez; Marina Bermisheva; Carl Blomqvist; Stig E Bojesen; Bernardo Bonanni; Anne-Lise Børresen-Dale; Hiltrud Brauch; Hermann Brenner; Angela Brooks-Wilson; Thomas Brüning; Barbara Burwinkel; Saundra S Buys; Federico Canzian; Jose E Castelao; Jenny Chang-Claude; Stephen J Chanock; Georgia Chenevix-Trench; Christine L Clarke; J Margriet Collée; Angela Cox; Simon S Cross; Kamila Czene; Mary B Daly; Peter Devilee; Thilo Dörk; Miriam Dwek; Diana M Eccles; D Gareth Evans; Peter A Fasching; Jonine Figueroa; Giuseppe Floris; Manuela Gago-Dominguez; Susan M Gapstur; José A García-Sáenz; Mia M Gaudet; Graham G Giles; Mark S Goldberg; Anna González-Neira; Grethe I Grenaker Alnæs; Mervi Grip; Pascal Guénel; Christopher A Haiman; Per Hall; Ute Hamann; Elaine F Harkness; Bernadette A M Heemskerk-Gerritsen; Bernd Holleczek; Antoinette Hollestelle; Maartje J Hooning; Robert N Hoover; John L Hopper; Anthony Howell; Milena Jakimovska; Anna Jakubowska; Esther M John; Michael E Jones; Audrey Jung; Rudolf Kaaks; Saila Kauppila; Renske Keeman; Elza Khusnutdinova; Cari M Kitahara; Yon-Dschun Ko; Stella Koutros; Vessela N Kristensen; Ute Krüger; Katerina Kubelka-Sabit; Allison W Kurian; Kyriacos Kyriacou; Diether Lambrechts; Derrick G Lee; Annika Lindblom; Martha Linet; Jolanta Lissowska; Ana Llaneza; Wing-Yee Lo; Robert J MacInnis; Arto Mannermaa; Mehdi Manoochehri; Sara Margolin; Maria Elena Martinez; Catriona McLean; Alfons Meindl; Usha Menon; Heli Nevanlinna; William G Newman; Jesse Nodora; Kenneth Offit; Håkan Olsson; Nick Orr; Tjoung-Won Park-Simon; Alpa V Patel; Julian Peto; Guillermo Pita; Dijana Plaseska-Karanfilska; Ross Prentice; Kevin Punie; Katri Pylkäs; Paolo Radice; Gad Rennert; Atocha Romero; Thomas Rüdiger; Emmanouil Saloustros; Sarah Sampson; Dale P Sandler; Elinor J Sawyer; Rita K Schmutzler; Minouk J Schoemaker; Ben Schöttker; Mark E Sherman; Xiao-Ou Shu; Snezhana Smichkoska; Melissa C Southey; John J Spinelli; Anthony J Swerdlow; Rulla M Tamimi; William J Tapper; Jack A Taylor; Lauren R Teras; Mary Beth Terry; Diana Torres; Melissa A Troester; Celine M Vachon; Carolien H M van Deurzen; Elke M van Veen; Philippe Wagner; Clarice R Weinberg; Camilla Wendt; Jelle Wesseling; Robert Winqvist; Alicja Wolk; Xiaohong R Yang; Wei Zheng; Fergus J Couch; Jacques Simard; Peter Kraft; Douglas F Easton; Paul D P Pharoah; Marjanka K Schmidt
Journal:  Breast Cancer Res       Date:  2022-01-04       Impact factor: 8.408

8.  Microsatellite instability in early sporadic breast cancer.

Authors:  J A Shaw; T Walsh; S A Chappell; N Carey; K Johnson; R A Walker
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.